Participations à des congrès et colloques internationaux (65)
  1. 47. Van Woensel, M., Wauthoz, N., Rosiere, R., Amighi, K., Mathieu, V., Lefranc, F., Van Gool, S. W., Mathivet, T., & De Vleeschouwer, S. (2014). Intranasal delivery of anti-Galectin-1 formulation to increase the efficiency of chemo- and immunotherapy for glioblastoma. Poster présenté à la conférence Belgian Society of Neurosurgery (29/03/2014: Brussels).
  2. 48. Rosiere, R., Wauthoz, N., Gelbcke, M., Van Antwerpen, P., & Amighi, K. (2013). Development of new inhalable formulation for the lung cancers therapy. Paper session presented at Journée des Doctorants de sciences biomédicales, dentaires, sciences médicales et pharmaceutiques (13: 19/12/2013: Erasme).
  3. 49. Rosiere, R., Wauthoz, N., Gelbcke, M., Van Antwerpen, P., & Amighi, K. (2013). Development of new inhalable formulation for the lung cancers therapy. Paper session presented at Forum des sciences pharmaceutiques de la SBSP (17: 17-18/10/2013: Spa).
  4. 50. Duret, C., Wauthoz, N., Rosiere, R., Merlos, R., Sebti, T., Vanderbist, F., & Amighi, K. (2013). A new Inhaled Itraconazole Solid Dispersion for Inhalation against Invasive Pulmonary Aspergillosis. Poster présenté à la conférence Innovation in Drug Delivery (3 rd: 22-25/09/2013: Pise - Italie).
  5. 51. Wauthoz, N., & Amighi, K. (2013). Phospholipids as pulmonary excipient. Paper session presented at Symposium on Phospholipids in Pharmaceutical Research (3rd: 16-17/09/2013: Heidelberg - Allemagne).
  6. 52. Moysan, E., Wauthoz, N., Bastiat, G., & Benoit, J.-P. (2012). An original nanomedicine to deliver gemcitabine in lymph nodes invaded by metastasis. Poster présenté à la conférence GTRV Scientific Meeting (27th: 3-5 december 2012: Paris).
  7. 53. Wauthoz, N., Kiss, R., & Amighi, K. (2012). Temozolomide by inhalation for the treatment of lung tumors: Preclinical investigation and development of dry powder formulations for inhalation. Paper session presented at Nanomedicine in Oncology Workshop (26-29 September 2012: Berder, France).
  8. 54. Wauthoz, N., Kiss, R., & Amighi, K. (2012). Local Delivery of Temozolomide against Lung Tumors and Development of Dry Powders for Inhalation. Paper session presented at Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (8th World Meeting: 19.03.2012-22.03.2012: Istanbul).
  9. 55. Duret, C., Wauthoz, N., Goole, J., Sebti, M. T., Vanderbist, F., & Amighi, K. (2012). In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice. Poster présenté à la conférence 8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (19-22 mars 2012: Istanbull).
  10. 56. Duret, C., Wauthoz, N., Goole, J., Sebti, T., Vanderbist, F., & Amighi, K. (2012). Dry powder endotracheal insufflators device for use in dose dependent preclinical studies in mice. Poster présenté à la conférence 8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.
  11. 57. Duret, C., Wauthoz, N., Pilcer, G., Depreter, F., Sebti, T., & Amighi, K. (2011). The use of phospholipids as excipients in the developement of formulations for inhalation. Poster présenté à la conférence Phospholipids in Pharmaceutical Research (2nd: 12-09-2011 and 13-09-2011: Heidelberg).
  12. 58. Wauthoz, N., Deleuze, P., Saumet, A., Duret, C., Kiss, R., & Amighi, K. (2011). Temozolomide-based dry powder formulations for lung tumor-related inhalation treatments. Poster présenté à la conférence PharmSciFair (3rd: 13/06/2011-17/06/2011: Pragues).
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 Suivant >>